翻译纳米机器人瘤学:承诺,进步和持续的障碍
Ursula Abu Nahla1, Muhammad Suleman2, Inshrah Khan2
1Faculty of Medicine, Hebron University, Hebron, Palestine.
Annals of medicine and surgery (2012)
|January 7, 2026
概括
纳米机器人癌症疗法在精确药物输送方面表现有前途,但面临重大障碍. 克服临床验证,监管和制造方面的挑战对于将这些先进技术转化为患者护理至关重要.
科学领域:
- 在瘤学瘤学.
- 生物技术是生物技术.
- 纳米技术纳米技术
背景情况:
- 纳米机器人技术为精确的癌症治疗提供了潜力,包括有针对性的药物输送和降低毒性.
- 基因原形和磁导航系统显示出临床前的前景,理论上改善了传统的化疗.
- 显著的转化障碍阻碍了纳米机器人从实验室研究到临床应用的进展.
研究的目的:
- 评估纳米机器人技术在瘤学中面临的翻译挑战.
- 确定当前的研发途径中的关键缺口.
- 概述成功临床翻译所需的步骤.
主要方法:
- 审查现有的临床前证据和纳米机器人癌症治疗的理论框架.
- 确定监管,制造,安全和结果测量的限制.
- 对临床验证和多学科合作的要求进行分析.
主要成果:
- 目前的证据在很大程度上是临床前的,缺乏强大的临床验证和标准化的结果措施.
- 主要障碍包括不清楚的监管途径,制造可扩展性问题和不完整的长期安全评估.
- 不同质的研究努力和缺乏对比有效性研究阻碍了进步.
结论:
- 成功的翻译需要通过严格的评估来解决监管,制造和安全方面的问题.
- 建立患者登记册,验证指标,系统审查和全面的安全协议是必不可少的.
- 跨学科的合作对于推动纳米机器人瘤学从临床前的承诺到临床现实至关重要.
更多相关视频
07:54Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
8.6K
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
3.0K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Microorganisms in Medicine and Therapeutics
928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
The Nucleolus
10.2K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.2K
